Once rejected, FDA now rolls out a short red carpet for Amicus’ migalastat
Amicus CEO $FOLD John Crowley must have made a very favorable impression on the FDA as he lobbied senior officials to overturn their rejection of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
